A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
Clinical trial NCT05788289 · TERMINATED
Trial details
- NCT number
- NCT05788289
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2024-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.